{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T01:31:37Z","timestamp":1778203897944,"version":"3.51.4"},"reference-count":33,"publisher":"Japanese Pharmacological Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Folia Pharmacol. Jpn.","Folia Pharmacologica Japonica"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1254\/fpj.21052","type":"journal-article","created":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T22:11:56Z","timestamp":1646086316000},"page":"146-154","source":"Crossref","is-referenced-by-count":6,"title":["New drug for type 2 diabetes: introduction of oral Semaglutide (Rybelsus&lt;sup&gt;\u00ae&lt;\/sup&gt; tablets), an oral GLP-1 receptor agonist","2\u578b\u7cd6\u5c3f\u75c5\u6cbb\u7642\u5264 \u7d4c\u53e3GLP-1\u53d7\u5bb9\u4f53\u4f5c\u52d5\u85ac\uff1a\u7d4c\u53e3\u30bb\u30de\u30b0\u30eb\u30c1\u30c9\uff08\u30ea\u30d9\u30eb\u30b5\u30b9&lt;sup&gt;\u00ae&lt;\/sup&gt;\u9320\uff09\u306e\u85ac\u7406\u5b66\u7684\u7279\u6027\u3068\u81e8\u5e8a\u8a66\u9a13\u6210\u7e3e"],"prefix":"10.1254","volume":"157","author":[{"given":"Kota","family":"Miyasaka","sequence":"first","affiliation":[{"name":"CMR Development Division, Medical Affairs Department, Novo Nordisk Pharma Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"332","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Htike Z, et al. Diabetes Obes Metab. 2017;19:524-536.","DOI":"10.1111\/dom.12849"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Urquhart S, et al. JAAPA. 2020;33:19-30.","DOI":"10.1097\/01.JAA.0000669452.63883.45"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Seino Y, et al. J Diabetes Investig. 2013;4:108-130.","DOI":"10.1111\/jdi.12065"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Knudsen LB, et al. J Med Chem. 2000;43:1664-1669.","DOI":"10.1021\/jm9909645"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Aroda VR, et al. Diabetes Care. 2019;42:1724-1732.","DOI":"10.2337\/dc19-0749"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Rosenstock J, et al. JAMA. 2019;321:1466-1480.","DOI":"10.1001\/jama.2019.2942"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Pratley R, et al. Lancet. 2019;394:39-50.","DOI":"10.1016\/S0140-6736(19)31271-1"},{"key":"8","unstructured":"8) Zinman B, et al. Diabetes Care. 2019;42:2262-2271."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Yamada Y, et al. Lancet Diabetes Endocrinol. 2020;8:377-391.","DOI":"10.1016\/S2213-8587(20)30075-9"},{"key":"10","unstructured":"10) Yabe D, et al. Lancet Diabetes Endocrinol. 2020;8:392-406."},{"key":"11","unstructured":"11) Buckley ST, et al. Sci Transl Med. 2018;10:eaar7047."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Lau J, et al. J Med Chem. 2015;58:7370-7380.","DOI":"10.1021\/acs.jmedchem.5b00726"},{"key":"13","unstructured":"13) \u793e\u5185\u8cc7\u6599\uff0e\u98df\u4e8b\u306e\u5f71\u97ff\uff08NN9924-4154\u8a66\u9a13\uff09(2020\u5e746\u670829\u65e5\u627f\u8a8d, CTD2.7.2.3)."},{"key":"14","unstructured":"14) \u793e\u5185\u8cc7\u6599\uff0e\u6295\u4e0e\u5f8c\u306e\u7d76\u98df\u6642\u9593\uff08NN9924-3794\u8a66\u9a13\uff09(2020\u5e746\u670829\u65e5\u627f\u8a8d, CTD2.7.2.3)."},{"key":"15","unstructured":"15) \u793e\u5185\u8cc7\u6599\uff0e\u6295\u4e0e\u5f8c\u306e\u98f2\u6c34\u91cf\uff08NN9924-3957\u8a66\u9a13\uff09(2020\u5e746\u670829\u65e5\u627f\u8a8d, CTD2.7.2.3)."},{"key":"16","unstructured":"16) \u793e\u5185\u8cc7\u6599\uff0eFour weeks dose response study in db\/db mice of the GLP 1 analogue semaglutide with regard to its effects on blood glucose, food intake, body weight and beta cell function and mass. (MmLa070620) (2018\u5e743\u670823\u65e5\u627f\u8a8d \u30aa\u30bc\u30f3\u30d4\u30c3\u30af<sup>\u00ae<\/sup>\u76ae\u4e0b\u6ce82mg, CTD2.6.2.2)."},{"key":"17","unstructured":"17) \u793e\u5185\u8cc7\u6599\uff0eInsulin secretion in the isolated perfused rat pancreas in response to semaglutide (JStu050701) (2018\u5e743\u670823\u65e5\u627f\u8a8d \u30aa\u30bc\u30f3\u30d4\u30c3\u30af<sup>\u00ae<\/sup>\u76ae\u4e0b\u6ce82mg, CTD2.6.2.2)."},{"key":"18","unstructured":"18) \u793e\u5185\u8cc7\u6599\uff0eDuration of action of pharmacodynamic effect on insulin secretion in minipigs. (BidR050301) (2018\u5e743\u670823\u65e5\u627f\u8a8d \u30aa\u30bc\u30f3\u30d4\u30c3\u30af<sup>\u00ae<\/sup>\u76ae\u4e0b\u6ce82mg, CTD2.6.2.2)."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Kapitza C, et al. Diabetologia. 2017;60:1390-1399.","DOI":"10.1007\/s00125-017-4289-0"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Blundell J, et al. Diabetes Obes Metab. 2017;19:1242-1251.","DOI":"10.1111\/dom.12932"},{"key":"21","unstructured":"21) \u793e\u5185\u8cc7\u6599\uff0e\u7b2cI\u76f8\u81e8\u5e8a\u8a66\u9a13 (NN9535-3684) (2018\u5e743\u670823\u65e5\u627f\u8a8d \u30aa\u30bc\u30f3\u30d4\u30c3\u30af<sup>\u00ae<\/sup>\u76ae\u4e0b\u6ce82mg, CTD2.7.6.16)."},{"key":"22","unstructured":"22) \u793e\u5185\u8cc7\u6599\uff0e\u4ed6\u306e\u7d4c\u53e3\u85ac\u3068\u306e\u4f75\u7528\u6295\u4e0e\uff08NN9924-4279\u8a66\u9a13\uff09(2020\u5e746\u670829\u65e5\u627f\u8a8d, CTD2.7.2.3)."},{"key":"23","unstructured":"23) \u793e\u5185\u8cc7\u6599\uff0e\u6295\u4e0e\u3092\u5fd8\u308c\u305f\u5834\u5408 (2020\u5e746\u670829\u65e5\u627f\u8a8d, CTD2.7.2.3)."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Granhall C, et al. Clin Pharmacokinet. 2018;57:1571-1580.","DOI":"10.1007\/s40262-018-0649-2"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) B\u00e6kdal TA, et al. J Clin Pharmacol. 2018;58:1314-1323.","DOI":"10.1002\/jcph.1131"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) B\u00e6kdal TA, et al. Clin Pharmacokinet. 2019;58:1193-1203.","DOI":"10.1007\/s40262-019-00756-2"},{"key":"27","unstructured":"27) \u793e\u5185\u8cc7\u6599\uff0e\u7b2cI\u76f8\u81e8\u5e8a\u8a66\u9a13 (NN9924-4141) (2020\u5e746\u670829\u65e5\u627f\u8a8d, CTD2.7.2.3)."},{"key":"28","unstructured":"28) \u793e\u5185\u8cc7\u6599\uff0e\u7b2cI\u76f8\u81e8\u5e8a\u8a66\u9a13 (NN9924-4249) (2020\u5e746\u670829\u65e5\u627f\u8a8d, CTD2.7.2.3)."},{"key":"29","unstructured":"29) \u793e\u5185\u8cc7\u6599\uff0e\u7b2cI\u76f8\u81e8\u5e8a\u8a66\u9a13 (NN9924-4250) (2020\u5e746\u670829\u65e5\u627f\u8a8d, CTD2.7.2.3)."},{"key":"30","unstructured":"30) \u793e\u5185\u8cc7\u6599\uff0e\u7b2cI\u76f8\u81e8\u5e8a\u8a66\u9a13 (NN9924-4140) (2020\u5e746\u670829\u65e5\u627f\u8a8d, CTD2.7.2.3)."},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Davies M, et al. JAMA. 2017;318:1460-1470.","DOI":"10.1001\/jama.2017.14752"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Husain M, et al. N Engl J Med. 2019;381:841-851.","DOI":"10.1056\/NEJMoa1901118"},{"key":"33","unstructured":"33) American Diabetes Association. Diabetes Care. 2021;44:S111-S124."}],"container-title":["Folia Pharmacologica Japonica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fpj\/157\/2\/157_21052\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T06:25:39Z","timestamp":1700288739000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fpj\/157\/2\/157_21052\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1254\/fpj.21052","relation":{},"ISSN":["0015-5691","1347-8397"],"issn-type":[{"value":"0015-5691","type":"print"},{"value":"1347-8397","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"21052"}}